NCT06526078
Cognitive Training as an Adjunct to Ketamine in Real-world Clinics
Enrolling by Invitation
NAAges 18–80InterventionalTreatmentUniversity of PittsburghInvestigator-initiated
~600 participants
Updated 2026-04-20 on ClinicalTrials.gov
What's tested:Cognitive TrainingSham Training
At a glance
Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Montgomery Asberg Depression Rating Scale: During (Es)Ketamine Induction
Measured over Trajectories from baseline through end of 'induction phase' treatments (up to max of 12 weeks)
+1 more outcome measured
Conditions
Where it's being run
3 sites across 3 statesCalifornia1
Illinois1
Texas1
Study leadership
- Rebecca B Price, PhD · PRINCIPAL_INVESTIGATOR · University of Pittsburgh
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Montgomery Asberg Depression Rating Scale: During (Es)Ketamine InductionTrajectories from baseline through end of 'induction phase' treatments (up to max of 12 weeks)
depression severity; range 0-60; high score=worse outcome
- Montgomery Asberg Depression Rating Scale: After (Es)Ketamine InductionTrajectories from final 'induction phase' treatment through 4 weeks post-induction
depression severity; range 0-60; high score=worse outcome